D
Oaktree Acquisition Corp. III Life Sciences OACC
$10.60 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2025 06/30/2025
Total Cash And Short-Term Investments -- --
Total Receivables -- --
Inventory -- --
Prepaid Expenses -- --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets -- --

Total Current Assets -- --
Net Property, Plant & Equipment -- --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 31,162.77% 203,626.29%
Total Assets 31,394.52% 205,235.77%

Total Accounts Payable -- --
Total Accrued Expenses -- --
Short-term Debt -89.21% --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -- --
Total Finance Division Other Current Liabilities 46.77% 908.19%
Total Other Current Liabilities 46.77% 908.19%
Total Current Liabilities 85.29% 1,151.90%

Total Current Liabilities 85.29% 1,151.90%
Long-Term Debt -- --
Short-term Debt -89.21% --
Capital Leases -- --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -- --
Total Liabilities 31,317.40% 230,006.04%

Common Stock & APIC -98.00% -98.00%
Retained Earnings -13,964.86% -37,483.91%
Treasury Stock & Other -- --
Total Common Equity -29,184.42% -86,140.79%

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible -- --
Preferred Stock, Others -- --
Total Preferred Equity -- --

Total Common Equity -29,184.42% -86,140.79%
Total Preferred Equity -- --
Total Minority Interest -- --
Total Equity -29,184.42% -86,140.79%